Prostate-specific membrane antigen (PSMA)-directed positron emission tomography (PET)
has gained increasing interest for imaging of men affected by prostate cancer (PC). In recent …

Radiolabeled prostate-specific membrane antigen (PSMA) PET has demonstrated promising
results for prostate cancer (PCa) imaging. Quantification of PSMA radiotracer uptake is …

… restaging, and metastasis detection of prostate cancer (PCa). However, little is known about
the role of 18F-DCFPyL PET/CT in biochemically recurrent prostate cancer (BRPCa). Hence…

… 18F was the most widely used positron nuclide in clinical practice. 18F-DCFPyL was also a
… the accuracy and reliability of 18F-DCFPyL PSMA PET/CT in prostate cancer diagnosis, this …

… This study aimed to determine the sensitivity and safety of 18 F-DCFPyL PET/CT for the
detection of prostate cancer relapse in the context of biochemical recurrence. Since the initial …

… Prostate cancer (PCa) is the second leading cause of cancer … F-DCFPyL targets
prostate-specific membrane antigen (… of 18 F-DCFPyL with 18 F-NaF and 18 F-DCFPyL with 18 …

… Four biopsies were performed, all of which confirmed prostate adenocarcinoma at the sites
of 18 F-DCFPyL uptake. Three of the biopsy sites evaluated uptake in the prostate gland, and …

… This study demonstrated that both 18 F-DCFPyL and 18 F-PSMA-1007 are widely equivalent
for imaging of local and metastatic prostate cancer. Both tracers provide excellent image …

… rate of 18 F-DCFPyL PET/CT, a prostate-specific membrane antigen (PSMA)–targeted PET
agent, in patients with biochemically relapsed prostate cancer after primary local therapy. …

… studies of DCFPyL in patients with … ) prostate cancer, the OSPREY (Study of 18F-DCFPyL
PET/CT Imaging in Patients with Prostate Cancer) (15) and CONDOR (Study of 18F-DCFPyL …